Cargando…

Baseline SUVmax of (18)F-FDG PET-CT indicates prognosis of extranodal natural killer/T-cell lymphoma

To evaluate the prognostic value of the baseline SUVmax of (18)F-FDG PET-CT in extranodal natural killer/T-cell lymphoma (NKTCL) patients. From January 2010 to December 2015, 141 extranodal NKTCL patients with staging (18)F-FDG PET-CT scan were divided into two group based on SUVmax cutoff value obt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Xianwu, Wang, Yaqi, Yuan, Jianjun, Sun, Wenjie, Jiang, Jinjin, Liu, Chang, Zhang, Qunling, Ma, Xuejun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489640/ https://www.ncbi.nlm.nih.gov/pubmed/32925768 http://dx.doi.org/10.1097/MD.0000000000022143

Ejemplares similares

Nomograms based on SUVmax of (18)F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma
por: Li, Hongyan, et al.
Publicado: (2021)

Primary extranodal natural killer/T-cell nasal-type lymphoma of spine: A case report
por: Wang, Jie, et al.
Publicado: (2019)

Burkitt lymphoma and cavernous sinus syndrome with breast uptake on (18)F-FDG-PET/CT: A case report
por: Reyneke, Florette, et al.
Publicado: (2017)

PET-CT for Evaluation of Spleen and Liver (18)F-FDG Diffuse Uptake Without Lymph Node Enlargement in Lymphoma
por: Rao, Liangjun, et al.
Publicado: (2016)

Pulmonary Extranodal Natural Killer/T-Cell Lymphoma (Nasal Type): A Case Report and Radiological Image Review
por: Fei, Wang, et al.
Publicado: (2015)

Nasal-type extranodal natural killer/T-cell lymphoma presenting with a mass on the buttock: A case report
por: Liu, Shuzhong, et al.
Publicado: (2019)

Utility of baseline, interim and end-of-treatment (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma patients treated with L-asparaginase/pegaspargase
por: Chang, Yu, et al.
Publicado: (2017)

Prognostic value of baseline, interim and end-of-treatment (18)F-FDG PET/CT parameters in extranodal natural killer/T-cell lymphoma: A meta-analysis
por: Wang, Hongxi, et al.
Publicado: (2018)

Prognostic value of pretreatment (18)F-FDG PET-CT for nasopharyngeal carcinoma patients
por: Huang, Yecai, et al.
Publicado: (2017)

Multifocal extranodal lymphoma: A case report
por: Li, Chao, et al.
Publicado: (2016)

Extranodal manifestations of lymphoma on [(18)F]FDG-PET/CT: a pictorial essay
por: Kashyap, Raghava, et al.
Publicado: (2011)

Expression of Concern: Prognostic value of baseline, interim and end-of-treatment (18)F-FDG PET/CT parameters in extranodal natural killer/T-cell lymphoma: A meta-analysis
Publicado: (2023)

Diagnostic accuracy of (18)F-FDG PET/CT for detecting synchronous advanced colorectal neoplasia in patients with gastric cancer
por: Choi, Byung Wook, et al.
Publicado: (2016)

Glucose metabolism of visceral adipose tissue measured by (18)F-FDG PET/CT is related to the presence of colonic adenoma
por: Yoon, Hai-Jeon, et al.
Publicado: (2017)

Prognostic value of metabolic variables of [18F]FDG PET/CT in surgically resected stage I lung adenocarcinoma
por: Wang, Xiao-Yi, et al.
Publicado: (2017)

Correlation of 18F-FDG PET/CT SUVmax with clinical features, D-dimer and LDH in patients with primary intestinal lymphoma
por: Zhou, Shuo, et al.
Publicado: (2021)

(18)F-FDG PET/CT imaging for aggressive melanotic schwannoma of the L3 spinal root: A case report
por: Shen, Xun-Ze, et al.
Publicado: (2021)

GDP (Gemcitabine, Dexamethasone, and Cisplatin) Is Highly Effective and Well-Tolerated for Newly Diagnosed Stage IV and Relapsed/Refractory Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
por: Wang, Jing-jing, et al.
Publicado: (2016)

Prognostic value of (18)F-FDG PET-CT-based functional parameters in patients with soft tissue sarcoma: A meta-analysis
por: Chen, Linyan, et al.
Publicado: (2017)

Bone metastases with “false negative” findings on (18)F-FDG PET/CT in patients with angiosarcoma: A case series with literature review
por: Ariga, Akane, et al.
Publicado: (2023)

FDG PET/CT for evaluating systemic arterial inflammation induced by anthracycline-based chemotherapy of Hodgkin lymphoma: A retrospective cohort study
por: Lawal, Ismaheel O., et al.
Publicado: (2020)

Predictive value of Dmax and %ΔSUVmax of (18)F-FDG PET/CT for the prognosis of patients with diffuse large B-cell lymphoma
por: Dang, Jun, et al.
Publicado: (2023)

Preoperative Standardized Uptake Value of Metastatic Lymph Nodes Measured by (18)F-FDG PET/CT Improves the Prediction of Prognosis in Gastric Cancer
por: Song, Bong-Il, et al.
Publicado: (2015)

Predictive Value of (18)F-FDG PET and CT Morphologic Features for Recurrence in Pathological Stage IA Non-Small Cell Lung Cancer
por: Ko, Kai-Hsiung, et al.
Publicado: (2015)

Castleman disease in the hilum liver mimicking the lymph node metastasis of hepatocellular carcinoma on (18)F-FDG PET/CT: A case report
por: Hu, Yan, et al.
Publicado: (2018)

Weakly supervised deep learning for determining the prognostic value of (18)F-FDG PET/CT in extranodal natural killer/T cell lymphoma, nasal type
por: Guo, Rui, et al.
Publicado: (2021)

Comparison of different automated lesion delineation methods for metabolic tumor volume of (18)F-FDG PET/CT in patients with stage I lung adenocarcinoma
por: Wang, Xiao-Yi, et al.
Publicado: (2017)

Necrosis on pre-radiotherapy (18)F-FDG PET/CT is a predictor for complete metabolic response in patients with non-small cell lung cancer
por: Eren, Gülnihan, et al.
Publicado: (2022)

Repeatability of the Maximum Standard Uptake Value (SUVmax) in FDG PET
por: Lindholm, Henry, et al.
Publicado: (2014)

Prognostic significance of volume-based (18)F-FDG PET/CT parameters and correlation with PD-L1 expression in patients with surgically resected lung adenocarcinoma
por: Wang, Dalong, et al.
Publicado: (2021)

Metabolic activity of extranodal NK/T cell lymphoma on (18)F-FDG PET/CT according to immune subtyping
por: Lim, Chae Hong, et al.
Publicado: (2021)

Prediction of 2-[(18)F]FDG PET-CT SUVmax for Adrenal Mass Characterization: A CT Radiomics Feasibility Study
por: Stanzione, Arnaldo, et al.
Publicado: (2023)

SUVmax of (18)F-FDG PET/CT in the differential diagnosis of benign and malignant thyroid nodules according to tumor volume
por: Kim, Tae Heon, et al.
Publicado: (2015)

Prediction of Histologic Subtype and FNCLCC Grade by SUVmax Measured on (18)F-FDG PET/CT in Patients with Retroperitoneal Liposarcoma
por: Li, Cheng-Peng, et al.
Publicado: (2021)

The Value of (18)F-FDG PET/CT Imaging Combined With Pretherapeutic Ki67 for Early Prediction of Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
por: Luo, Jurui, et al.
Publicado: (2016)

Percentage change of primary tumor on (18)F-FDG PET/CT as a prognostic factor for invasive ductal breast cancer with axillary lymph node metastasis: Comparison with MRI
por: Yoo, Jang, et al.
Publicado: (2017)

Optimal Scan Time of (18)F-FDG PET in Identifying Therapeutic Efficacy Secondary to Radiofrequency Ablation of Lung Cancer: Case Report
por: Zhang, Wen-Qian, et al.
Publicado: (2015)

Does the SUVmax of FDG-PET/CT Correlate with the ADC Values of DWI in Musculoskeletal Malignancies?
por: Ozturk, Mesut, et al.
Publicado: (2021)

Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer
por: Im, Hyung-Jun, et al.
Publicado: (2016)

A Case of Extranodal Testicular Involvement in Non-Hodgkin’s Lymphoma Detected through (18)F-FDG PET-CT
por: Coulier, B., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_i3nc65hr0fjl6j1mf30ud89v7s